Vaccination

Valneva launches trials of COVID-19 vaccine in UK

French-Austrian biotech firm Valneva said Wednesday it will begin clinical trials of its COVID-19 vaccine candidate in Britain, where the government has already ordered at least 60 million doses.

Diseases, Conditions, Syndromes

WHO warns Christmas celebrations could turn to tears

The World Health Organization warned Friday that Christmas celebrations could turn to tears if people fail to keep up their guard against COVID-19 during the festive season.

Vaccination

Two vaccines hit snags as Pfizer nears US approval

Two vaccine candidates stumbled Friday in the race among researchers to combat COVID-19, a setback for the global immunisation effort even as the Pfizer-BioNTech jab neared approval in the US.

Diseases, Conditions, Syndromes

Sanofi, GSK say COVID-19 shot won't be ready until late 2021

Drugmakers Sanofi and GlaxoSmithKline said Friday that their potential COVID-19 vaccine won't be ready until late next year because they need to improve the shot's effectiveness in older people.

Vaccination

Vaccine documents hacked at EU medicines agency

Two pharmaceutical companies in line for first conditional approval for their COVID-19 vaccine by the EU's medicine regulator said Wednesday their documents were "unlawfully accessed" during a cyberattack on a European Medicines ...

Vaccination

Pfizer chief insists no corners cut on vaccine testing

Pfizer chief executive Albert Bourla said Tuesday he understands concerns around the speed at which pharmaceutical companies have produced COVID-19 vaccines, but insisted that no corners had been cut.

page 11 from 40